Early Investors: Holographic "Phones" Are Coming...
Is that coffee machine real or digital?

To potentially profit, click before Oct. 27th.
Learn more.
Stephen Hoge, insider at Moderna

Stephen Hoge Insider Information

President of Moderna
Stephen Hoge serves as the President of Moderna and leads all Research & Development for the company. Since Moderna’s early days, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic areas. More recently, he has assumed responsibility for the company’s Clinical Development Office. He joined Moderna in late 2012 from McKinsey & Company, where he was a partner in the healthcare practice. Prior to McKinsey, Dr. Hoge was a resident physician in New York City.

He holds an M.D. with thesis from the University of California, San Francisco, and a B.S. in neuroscience from Amherst College.

Currently, Dr. Hoge also serves on the Board of Directors of Axcella Health, Inc., a publicly traded, clinical-stage biotechnology company.

What is Stephen Hoge's net worth?

The estimated net worth of Stephen Hoge is at least $694.50 million as of September 13th, 2021. Dr. Hoge owns 1,614,597 shares of Moderna stock worth more than $694,502,754 as of September 26th. This net worth approximation does not reflect any other assets that Dr. Hoge may own. Learn More.

What is Stephen Hoge's salary?

As the President of Moderna, Inc., Dr. Hoge earned a total compensation package of $4,247,823.00 in 2020. Dr. Hoge earned a salary of $548,712.00, a bonus of $662,400.00, stock awards of $750,000.00, options awards of $2,250,000.00, and other compensation of $36,711.00.

How do I contact Stephen Hoge?

The corporate mailing address for Dr. Hoge and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected]

Has Stephen Hoge been buying or selling shares of Moderna?

In the last ninety days, Stephen Hoge has sold $31,620,650.00 of Moderna stock. Most recently, Stephen Hoge sold 20,000 shares of the business's stock in a transaction on Monday, September 13th. The shares were sold at an average price of $447.41, for a transaction totalling $8,948,200.00. Following the completion of the sale, the president now directly owns 1,614,597 shares of the company's stock, valued at $722,386,843.77.

Who are Moderna's active insiders?

Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (CEO), W. Cornwell (Director), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), and Tal Zaks (Insider).

Are insiders buying or selling shares of Moderna?

During the last year, Moderna insiders bought shares 3 times. They purchased a total of 423,616 shares worth mmore than $15,619,184.48. During the last year, insiders at the sold shares 195 times. They sold a total of 7,069,704 shares worth mmore than $1,083,668,707.65. The most recent insider tranaction occured on September, 22nd when Stephane Bancel CEO bought 9,000 shares worth more than $3,897,000.00. Insiders at Moderna own 19.4 % of the company.

Information on this page was last updated on 9/22/2021.

Stephen Hoge Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Sell20,000$447.41$8,948,200.001,614,597View SEC Filing Icon  
9/2/2021Sell10,000$393.13$3,931,300.001,619,597View SEC Filing Icon  
8/13/2021Sell15,000$405.00$6,075,000.001,614,597View SEC Filing Icon  
7/26/2021Sell5,000$351.99$1,759,950.005,000View SEC Filing Icon  
7/23/2021Sell15,000$335.13$5,026,950.001,614,597View SEC Filing Icon  
7/13/2021Sell15,000$238.87$3,583,050.001,614,597View SEC Filing Icon  
7/6/2021Sell10,000$229.62$2,296,200.001,619,597View SEC Filing Icon  
6/23/2021Sell15,000$216.20$3,243,000.001,614,597View SEC Filing Icon  
6/14/2021Sell20,000$213.32$4,266,400.001,614,597View SEC Filing Icon  
4/23/2021Sell15,000$172.19$2,582,850.001,614,597View SEC Filing Icon  
4/13/2021Sell15,000$146.62$2,199,300.001,614,597View SEC Filing Icon  
4/5/2021Sell20,000$132.63$2,652,600.001,619,597View SEC Filing Icon  
3/24/2021Sell5,000$137.07$685,350.001,614,597View SEC Filing Icon  
3/15/2021Sell15,000$137.00$2,055,000.001,614,597View SEC Filing Icon  
3/12/2021Sell5,000$134.04$670,200.001,614,597View SEC Filing Icon  
2/23/2021Sell15,000$147.08$2,206,200.001,629,597View SEC Filing Icon  
2/12/2021Sell5,000$185.00$925,000.001,624,597View SEC Filing Icon  
1/25/2021Sell20,000$140.97$2,819,400.001,649,597View SEC Filing Icon  
1/13/2021Sell15,000$123.70$1,855,500.001,644,597View SEC Filing Icon  
12/23/2020Sell10,000$124.14$1,241,400.001,734,597View SEC Filing Icon  
12/14/2020Sell20,000$163.63$3,272,600.001,744,597View SEC Filing Icon  
12/2/2020Sell10,000$138.57$1,385,700.001,744,597View SEC Filing Icon  
11/24/2020Sell5,000$97.93$489,650.001,754,597View SEC Filing Icon  
10/26/2020Sell5,000$69.99$349,950.001,926,530View SEC Filing Icon  
10/23/2020Sell15,000$70.02$1,050,300.001,926,530View SEC Filing Icon  
10/12/2020Sell5,000$74.46$372,300.001,925,521View SEC Filing Icon  
10/5/2020Sell10,000$69.50$695,000.001,936,530View SEC Filing Icon  
10/2/2020Sell10,000$67.86$678,600.001,936,530View SEC Filing Icon  
9/24/2020Sell20,000$66.72$1,334,400.001,946,530View SEC Filing Icon  
9/14/2020Sell20,000$61.42$1,228,400.001,956,530View SEC Filing Icon  
9/2/2020Sell10,000$62.89$628,900.001,956,530View SEC Filing Icon  
8/24/2020Sell20,000$64.99$1,299,800.001,966,530View SEC Filing Icon  
8/3/2020Sell20,000$74.89$1,497,800.001,976,530View SEC Filing Icon  
7/24/2020Sell20,000$78.86$1,577,200.001,986,530View SEC Filing Icon  
7/13/2020Sell10,000$69.92$699,200.001,986,530View SEC Filing Icon  
7/6/2020Sell10,000$58.48$584,800.001,986,540View SEC Filing Icon  
7/2/2020Sell10,000$59.94$599,400.001,986,540View SEC Filing Icon  
6/23/2020Sell5,000$63.69$318,450.001,983,531View SEC Filing Icon  
5/26/2020Sell10,000$61.85$618,500.002,005,495View SEC Filing Icon  
5/12/2020Sell5,000$64.50$322,500.002,015,657View SEC Filing Icon  
4/23/2020Sell5,000$49.02$245,100.002,025,140View SEC Filing Icon  
3/23/2020Sell5,000$27.93$139,650.002,045,267View SEC Filing Icon  
1/23/2020Sell5,000$21.99$109,950.002,081,915View SEC Filing Icon  
1/13/2020Sell10,000$19.14$191,400.002,086,530View SEC Filing Icon  
See Full Table

Stephen Hoge Buying and Selling Activity at Moderna

This chart shows Stephen Hoge's buying and selling at Moderna by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Moderna Company Overview

Moderna logo
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $430.14
Low: $426.61
High: $453.60

50 Day Range

MA: $396.12
Low: $307.33
High: $484.47

2 Week Range

Now: $430.14
Low: $65.49
High: $497.49


12,964,530 shs

Average Volume

13,057,122 shs

Market Capitalization

$173.63 billion

P/E Ratio


Dividend Yield



717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.